DNV Capital 德诺资本

8 employees

DNV capital is an international venture capital firm focusing on the investments in healthcare and innovative technology industry.

Investor insights

Sectors invested in

Biotechnology4

Health Care3

Medical3

Medical Device2

Precision Medicine1

Life Science1

Comprehensive Genomic profiling1

Cancer Genomics1

covert edible bar code1

Advanced Materials1

digital health1

optics1

traceability1

on-dose authentication1

Health Diagnostics1

Product Security1

Pharmaceutical1

smart medicine1

hyperspectral imaging1

Root Canal Treatment1

Funding rounds participated in

$17M sweet spot round size

Most of their 8 investments are in rounds between $3M and $35M

Basic info

Industry

venture capital and private equity principals

Sectors

Medical treatment and Health and Innovative technology

Date founded

2011

Investments made

Undisclosed raised undisclosed on April 4, 2023

Investors: Loyal Valley Capital, 新宜资本 and DNV Capital 德诺资本

华

华科精准（北京）医疗科技有限公司 raised $43M on December 26, 2022

Investors: 苏州凯风正德投资管理有限公司 and DNV Capital 德诺资本

Undisclosed raised $47M on April 19, 2022

Investors: Yangtze River Pharmaceutical Group Pharmaceutical Co., Ltd. and DNV Capital 德诺资本

Geneseeq Technology Inc. raised $7.3M on February 1, 2017

Investors: DNV Capital 德诺资本

Sonendo®, Inc. raised $35M on December 13, 2016

Investors: Meritech Capital Partners, OrbiMed Advisors and DNV Capital 德诺资本

浙

浙江今复康生物科技有限公司 raised $473K on October 9, 2015

Investors: Qiming Venture Partners and DNV Capital 德诺资本

Angioslide raised $3M on May 1, 2015

Investors: Triventures, Agate Medical Investments Group and DNV Capital 德诺资本

TruTag Technologies raised $17M on June 16, 2014

Investors: WuXi AppTec and DNV Capital 德诺资本